However, the apoptotic cell rates in tumor grafts treated with TRAIL/PDT and IgBD-TRAIL/PDT were 35.8±19.3% and 86.5±8.1%, respectively, which are much higher than their monotherapies. The gene discussed is TNFSF10; the disease is neoplasm.